Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
GLUCK FREDERICK W
Director at CytomX Therapeutics · Director at Amgen. Filing since 27 Jan 2009.
CIK 0001184126
CTMX
CytomX Therapeutics, Inc.
Director · 10 trades
AMGN
Amgen
Director · 3 trades
Company
Date
Role
Action
Shares
Amount
Of holding
CTMX
CytomX Therapeutics, Inc.
26 Mar 2018
Director
Sold, plan not stated
5,000
$159.64K
1.8%
CTMX
CytomX Therapeutics, Inc.
2 Mar 2018
Director
Sold, plan not stated
16,181
$485.47K
5.5%
CTMX
CytomX Therapeutics, Inc.
28 Feb 2018
Director
Sold, plan not stated
3,819
$114.57K
1.3%
CTMX
CytomX Therapeutics, Inc.
5 Jan 2018
Director
Sold, plan not stated
10,000
$250.08K
3.3%
CTMX
CytomX Therapeutics, Inc.
26 Dec 2017
Director
Sold, plan not stated
5,000
$111.43K
1.6%
CTMX
CytomX Therapeutics, Inc.
4 Oct 2017
Director
Sold, plan not stated
10,000
$242.68K
3.1%
CTMX
CytomX Therapeutics, Inc.
26 Sep 2017
Director
Sold, plan not stated
5,000
$86.48K
1.5%
CTMX
CytomX Therapeutics, Inc.
26 Jun 2017
Director
Sold, plan not stated
5,000
$73.05K
1.5%
CTMX
CytomX Therapeutics, Inc.
14 Oct 2015
Director
Bought
10,000
$120.00K
7.3%
CTMX
CytomX Therapeutics, Inc.
14 Oct 2015
Director
Bought
5,000
$60.00K
opened
AMGN
Amgen
8 Sep 2010
Director
Sold, plan not stated
800
$41.89K
4.8%
AMGN
Amgen
26 Aug 2010
Director
Sold, plan not stated
800
$41.40K
4.6%
AMGN
Amgen
27 Jan 2009
Director
Sold, plan not stated
16,000
$852.61K
54.0%
13 decisions on file.
